Legal / IP

AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Patents

CNIPA Launches Pilot for Priority Patent Review for Macau Applicants in Mainland China

CancerFRA: MVR0

Medivir AB Receives Chinese Patent Approval for Liver Cancer Treatment Fostroxacitabine Bralpamide

AbbVieBeiGene

AbbVie Inc. Files Lawsuit Against BeiGene Over BTK Inhibitor Brukinsa

Grand PharmaceuticalHKG: 0512

SAMR Imposes Penalties on Grand Pharma and WuHan Huihai for Monopoly Agreements

Show More